Global Smart Pills Technology Market is expected to garner $1212.1 million by 2027, registering a CAGR of 23.2% during the forecast period 2019-2027.
Smart Pills technology is a radical technological innovation which has bridged the gap between healthcare and digital technology. Smart Pills also known as Nootropics are simply the medical devices and small encapsulated electronic appliances such as sensors, cameras and trackers. Entire evaluation of the gastrointestinal tract (GIT) is possible through this electronic device which can be effortlessly gulped. The rising demand of better diagnostics and monitoring has been approached by the emergence of these healthcare-cum-technology devices. The conventional GI monitoring endoscopy has been excelled with more favourable smart Pills technology, which has now turned up as the standard non-invasive diagnosis technique for motility disorders. Further, with the remote controlling options, it aids the physicians in monitoring the patient in real-time.
Classification of the smart Pills technology market can be based on product type, patient monitoring devices, drug delivery system and capsule endoscopy system. Wireless health monitoring and site specific drug delivery are the factors anticipated to aid the acceptance of these technologies by patients as well as physicians. The diagnosis of GI disorders is carried by capsule endoscopy also termed as GI capsule or camera capsule, Pills cams or wireless endocapsule. Microcapsule consisting of four components namely, a light source, color camera, transmitter and battery are the devices of capsule endoscopy. Capsule endoscopy is accessible with great degree of flexibility. Wireless patient monitoring as well as smart Pills for drug delivery (also known as intelligent drug delivery or Bio-MEMS drug delivery system) are still among the developing technologies.
The extensive assessment of the smart Pills technology market along with the cautious insights, facts, historical data, and statistically supported and industry-validated market data are covered in the research report. Estimates inclusive of competent set of assumptions and methodologies are also attributed in the report. The research report furnishes the analysis and information as per the classification based on market segments, geographies, types, technology and applications.
The prominent players of Smart Pills Technology Market are Boston Scientific Corporation, GE Healthcare, Stryker Corporation, Siemens Healthcare, Pentax Medical Company, Medtronic, Inc, Olympus Medical Technology, Smart Pills Inc, Philips Healthcare, Philips Healthcare, Given Imaging Ltd and Novartis.
North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa are the key regions of the global Smart Pills Technology Market, classified geographically. In 2014, the highest market share in the overall smart Pills technology market is additionally backed by North America and Europe. Half the share of market revenue was garnered by North America in 2014. The advance deployment of novel technologies, a huge patient population, high disposable incomes and the fresh marketing and commercializing of smart Pills products are the factors contributing the growth in this region. With the enhanced healthcare awareness, Asia Pacific is estimated to grow at a commendable CAGR for smart Pills technologies market.
Smart Pills Technology Market Key Market Segments:
The Global Smart Pills technology market segmentation is illustrated below:
• Capsule endoscopy technology
• Capsule endoscope
• Small bowel capsule endoscope
• Colon capsule endoscope
• Esophagus capsule endoscope
• Workstations and recorders
• Gastrointestinal Monitoring Technology
• Single parameter (pH) monitoring
• Multi parameter (pH, temp, pressure) monitoring
Smart Pills Technology Market by Application
• North America
• Rest of Europe
• Australia & New Zealand
• Rest of Asia-Pacific
• Latin America
• Middle East
TOC NOT FOUND
Abstract Market Research
Call at: +1-209-813-4101 | +91-9730047721